RU2019137022A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2019137022A3 RU2019137022A3 RU2019137022A RU2019137022A RU2019137022A3 RU 2019137022 A3 RU2019137022 A3 RU 2019137022A3 RU 2019137022 A RU2019137022 A RU 2019137022A RU 2019137022 A RU2019137022 A RU 2019137022A RU 2019137022 A3 RU2019137022 A3 RU 2019137022A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201711014459 | 2017-04-24 | ||
IN201711014459 | 2017-04-24 | ||
PCT/IB2018/052822 WO2018198021A1 (en) | 2017-04-24 | 2018-04-24 | Therapeutic regimen of 2-amino-l-(2-(4-fluorophenyl)-3-(4-fluorophenylamino)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8h)-yl)ethanone and combinations thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
RU2019137022A RU2019137022A (ru) | 2021-05-25 |
RU2019137022A3 true RU2019137022A3 (ru) | 2021-08-31 |
RU2791466C2 RU2791466C2 (ru) | 2023-03-09 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
CA3059327A1 (en) | 2018-11-01 |
CN110691597A (zh) | 2020-01-14 |
TW201842911A (zh) | 2018-12-16 |
TWI791515B (zh) | 2023-02-11 |
US20180303837A1 (en) | 2018-10-25 |
WO2018198021A1 (en) | 2018-11-01 |
JP2020517660A (ja) | 2020-06-18 |
US20200171037A1 (en) | 2020-06-04 |
RU2019137022A (ru) | 2021-05-25 |
AU2021202235A1 (en) | 2021-05-13 |
AU2018260414A1 (en) | 2019-10-17 |
US20240180913A1 (en) | 2024-06-06 |
EP3615030A1 (en) | 2020-03-04 |
AU2021202235B2 (en) | 2023-03-23 |
JP7377717B2 (ja) | 2023-11-10 |
US20220088022A1 (en) | 2022-03-24 |
US11738028B2 (en) | 2023-08-29 |
KR20190139291A (ko) | 2019-12-17 |
MX2019012758A (es) | 2019-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR122021024397A2 (ru) | ||
BR122021023687A2 (ru) | ||
BR122021000189A2 (ru) | ||
BR122022025811B8 (ru) | ||
BR112019008823A2 (ru) | ||
BR112020006084A8 (ru) | ||
BR112019025295B1 (pt) | Compostos, composição, uso de um composto da fórmula i, método para combater fungos fitopatogênicos e semente revestida | |
BR122021014832A2 (ru) | ||
BR202018014992U2 (ru) | ||
BR122022003521A2 (ru) | ||
BR112020008820A2 (ru) | ||
BR202017025154U2 (ru) | ||
BR102017023327A2 (ru) | ||
BR202017021228U2 (ru) | ||
BR202017020981U2 (ru) | ||
BE2017C035I2 (ru) | ||
BR202017016984U2 (ru) | ||
BR202017016924U2 (ru) | ||
BR102017015495A2 (ru) | ||
BR102017015250A2 (ru) | ||
BR102017014430A2 (ru) | ||
BR202017012548U2 (ru) | ||
BR202017011220U2 (ru) | ||
BR202017010814U2 (ru) | ||
BR202017010373U2 (ru) |